Related Experiment Videos
[Pseudohypoparathyroidism type I and vitamin D therapy]
Acta Medica Austriaca
|January 1, 1978
Summary
Vitamin-D treatment can correct hypocalcemia in pseudohypoparathyroidism type I. However, the varied patient responses suggest heterogeneous vitamin D metabolism disturbances in this condition.
Area of Science:
- Endocrinology
- Metabolic Bone Disease
Context:
- Pseudohypoparathyroidism type I (PHP1) is a condition characterized by resistance to parathyroid hormone.
- Vitamin D metabolism plays a crucial role in calcium homeostasis, which is often affected in PHP1.
Purpose:
- To investigate the heterogeneity of vitamin D metabolism disturbances in pseudohypoparathyroidism type I.
- To assess the efficacy of different vitamin D analogs in normalizing serum calcium levels in PHP1 patients.
Summary:
- Pharmacologic doses of vitamin D can correct hypocalcemia in PHP1.
- Previous studies indicated impaired renal conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D in PHP1 patients.
- Treatment with vitamin D-3 and 1 alpha-hydroxycholecalciferol showed nonuniform normalization of serum calcium, suggesting metabolic heterogeneity.
Impact:
- Highlights the diverse nature of vitamin D metabolism defects in pseudohypoparathyroidism type I.
- Suggests that individualized treatment strategies may be necessary for managing hypocalcemia in PHP1.
- Informs future research on the specific molecular mechanisms underlying vitamin D resistance in PHP1.